✦ LIBER ✦

Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients

✍ Scribed by B. Persson; M. Stimpel

Publisher: Springer
Year: 1996
Tongue: English
Weight: 254 KB
Volume: 50
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s002280050104

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of spirapril, a new

Efficacy and safety of spirapril, a new ace-inhibitor, in elderly hypertensive patients

✍ I. Kantola; A. Terént; T. Honkanen; V. Järveläinen; K. Ekman; M. Kataja 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 241 KB

The efficacy and tolerability of aceclof

The efficacy and tolerability of aceclofenac compared to indomethacin in patients with rheumatoid arthritis

✍ D. Kornasoff; J. Maisenbacher; J. Bowdler; A. Raber 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 567 KB

A randomised, double-blind comparison of

A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia

✍ Ingvar Karlsson; Jan Godderis; Carlos Augusto De Mendonça Lima; Harald Nygaard; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB 👁 3 views

Depression is the most common psychiatric disorder among the elderly and in old age may interact with emotional and cognitive functioning. Depression in old age has been shown to be associated with degenerative changes in the brain. It is, therefore, important that in this patient population antidep

A multicenter, randomized, double-blind

A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: Results of a phase III clinical trial

✍ Daniel L. Rubin; Terry S. Desser; Richard Semelka; Jeffrey Brown; Hanh V. Nghiem 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 3 views

A pilot study to evaluate the safety and

A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 trap) in patients with familial cold autoinflammatory syndrome

✍ Raphaela Goldbach-Mansky; Sharukh D. Shroff; Mildred Wilson; Christopher Snyder; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB 👁 2 views

A multicentre, randomized, double-blind,

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre